Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas | Zendy

Scott D. Solomon | Zendy; Marc A. Pfeffer | Zendy; John J.V. McMurray | Zendy; Rob Fowler | Zendy; Peter Finn | Zendy; Bernard Levin | Zendy; Craig Eagle | Zendy; Ernest T. Hawk | Zendy; Mariajosé Lechuga | Zendy; Ann G. Zauber | Zendy; Monica M. Bertagnolli | Zendy; Nadir Arber | Zendy; Janet Wittes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas

Author(s) -

Scott D. Solomon,

Marc A. Pfeffer,

John J.V. McMurray,

Rob Fowler,

Peter Finn,

Bernard Levin,

Craig Eagle,

Ernest T. Hawk,

Mariajosé Lechuga,

Ann G. Zauber,

Monica M. Bertagnolli,

Nadir Arber,

Janet Wittes

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.636746

Subject(s) - medicine , celecoxib , hazard ratio , myocardial infarction , blood pressure , placebo , adenoma , stroke (engine) , colorectal adenoma , confidence interval , rofecoxib , colorectal cancer , surgery , gastroenterology , cancer , cyclooxygenase , pathology , mechanical engineering , biochemistry , chemistry , alternative medicine , engineering , enzyme

Cyclooxygenase-2 (COX-2) inhibitors have been shown to reduce colorectal adenomas but have been associated with increased cardiovascular risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research